... shares are traded on the Tel Aviv Stock Exchange (NASDAQ: XTLB, TASE: XTLB). Annual and Interim Reports · Presentation. Clicking on the below links will cause ...
$2.81
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of pharmaceutical products for the treatment of unmet clinical needs.
Find the latest XTL Biopharmaceuticals Ltd. (XTLB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: investor relations
XTL Biopharmaceuticals Ltd. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View XTLB.IL financial statements in full.
Missing: relations | Show results with:relations
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) will release its next earnings report on Dec 4, 2023. In the last quarter XTL Biopharmaceuticals Ltd.
Missing: relations | Show results with:relations
Investor Relations, XTL Biopharmaceuticals Ltd. Tel: +972 9 955 7080, Email: ir@xtlbio.com. Cautionary Statement. Some of the statements included in this Form ...
XTL Biopharmaceuticals Ltd. (XTLB) Financial Statements - FinChat.io
finchat.io › company › TASE-XTLB
Financials Investor Relations Estimates Industry Modeling Dividends Ownership Filings. Hide Summary. Basic. Market Cap. ₪50.68M. EV. ₪42.26M. Shares Out.
Mar 20, 2024 · The Investment is conditioned upon obtaining shareholders' approval as Mr. Alexander Rabinovich, a 23.5% shareholder and a director of the ...
XTLB | A complete XTLB overview by MarketWatch. View the latest market news and prices, and trading information.
Missing: relations | Show results with:relations